PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Arrowhead Research Corp. (ARWR) on Monday reported a loss of $173.1 million in its fiscal first quarter.
The Pasadena, California-based company said it had a loss of $1.39 per share.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.
The drug developer posted revenue of $2.5 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $169.6 million.
Arrowhead Research shares have climbed nearly 7% since the beginning of the year. In the final minutes of trading on Monday, shares hit $20.04, a decrease of 35% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARWR at https://www.zacks.com/ap/ARWR
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。